RAD51 and head and neck squamous cell carcinoma: Our studies showed that Rad51 did not colocalize to the sites of DNA damage in HPV+ HNSCC after HU treatment (Figure 4B) and that HPV+ cells did not activate a homologous recombination reporter after nuclease-induced DNA strand breaks (Figure 4C) [22,23].